Where We Are and Where Do We Need to Go?

February 27, 2015 7:55 PM

13 0

“All in this room are acutely aware of the scope of the HIV pandemic, with an unacceptable pace of 6,000 new daily HIV infections. These infections continue despite the availability of a robust portfolio of prevention tools, many of which when used in combination lead to prophylactic synergies,” said Raphael J. Landovitz, associate professor in the Division of Infectious Diseases, UCLA, Los Angeles, CA, at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, WA.

Landovitz shared updates on the current state of pre-exposure prophylaxis (PrEP) for HIV prevention and the need to mobilize clinical efforts, service delivery, education, implementation research, and policy to optimize PrEP access and use.

Read more

To category page